ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,225, issued on Sept. 29, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"LZK-targeting degraders and methods of use" was invented by John F. Brognard (Middletown, Md.), Rolf E. Swenson (Silver Spring, Md.), Amy L. Funk (Frederick, Md.), Carolyn W. Hitko (Olney, Md.), Katherine M. Nyswaner (Keedysville, Md.), Eric Lindberg (Rockville, Md.), Venkatareddy Sabbasani (Monrovia, Md.) and Knickole L. Bergman (Jefferson, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Leucine zipper-bearing kinase (LZK) targeted degraders are disclosed. The compounds have a general ...